OBJECTIVE: We evaluated the sensitivity of pulsed Arterial Spin Labelling (pASL) for the detection of changes in regional cerebral blood perfusion (CBP) during and after intra-venous (i.v.) infusion of an opioid agonist (fentanyl) and an opioid antagonist (naloxone). MATERIALS AND METHODS: Twenty-three subjects were scanned four times, receiving i.v. infusion of fentanyl, naloxone, placebo and a second fentanyl administration, in four separate scanning sessions in randomised order. End-tidal CO(2), respiration rate and heart rate were recorded continuously throughout each scan. pASL time series were collected using single shot EPI for 15 min (including 5 min of baseline prior to infusion). RESULTS: Significant increases in CBP were detected during and after administration of fentanyl, (when compared to placebo and naloxone), in most areas of high concentration of mu-opioid receptors (thalamus, lingual gyrus, para-hippocampal gyrus, and insula); near-significant increases were also observed in the insula. No increases in perfusion were observed during or after naloxone infusion. No correlation was found between regional rCBF changes and end-tidal CO(2), respiration rate or heart rate. Good reliability was found between the first and second fentanyl sessions but the regions of high reliability did not overlap completely with those of highest perfusion change. CONCLUSION:pASL is a suitable method for examining rapid, dynamic effects of opioid administration on brain physiology.
RCT Entities:
OBJECTIVE: We evaluated the sensitivity of pulsed Arterial Spin Labelling (pASL) for the detection of changes in regional cerebral blood perfusion (CBP) during and after intra-venous (i.v.) infusion of an opioid agonist (fentanyl) and an opioid antagonist (naloxone). MATERIALS AND METHODS: Twenty-three subjects were scanned four times, receiving i.v. infusion of fentanyl, naloxone, placebo and a second fentanyl administration, in four separate scanning sessions in randomised order. End-tidal CO(2), respiration rate and heart rate were recorded continuously throughout each scan. pASL time series were collected using single shot EPI for 15 min (including 5 min of baseline prior to infusion). RESULTS: Significant increases in CBP were detected during and after administration of fentanyl, (when compared to placebo and naloxone), in most areas of high concentration of mu-opioid receptors (thalamus, lingual gyrus, para-hippocampal gyrus, and insula); near-significant increases were also observed in the insula. No increases in perfusion were observed during or after naloxone infusion. No correlation was found between regional rCBF changes and end-tidal CO(2), respiration rate or heart rate. Good reliability was found between the first and second fentanyl sessions but the regions of high reliability did not overlap completely with those of highest perfusion change. CONCLUSION: pASL is a suitable method for examining rapid, dynamic effects of opioid administration on brain physiology.
Authors: T E Schlaepfer; E C Strain; B D Greenberg; K L Preston; E Lancaster; G E Bigelow; P E Barta; G D Pearlson Journal: Am J Psychiatry Date: 1998-04 Impact factor: 18.112
Authors: Julia M Lappin; Suzanne J Reeves; Mitul A Mehta; Alice Egerton; Mark Coulson; Paul M Grasby Journal: J Cereb Blood Flow Metab Date: 2008-12-17 Impact factor: 6.200
Authors: Ruth L O'Gorman; Mitul A Mehta; Philip Asherson; Fernando O Zelaya; Keeley J Brookes; Brian K Toone; David C Alsop; Steven C R Williams Journal: Neuroimage Date: 2008-04-20 Impact factor: 6.556
Authors: Ed Bullmore; John Suckling; Fernando Zelaya; Chris Long; Garry Honey; Laurence Reed; Carol Routledge; Virginia Ng; Paul Fletcher; John Brown; Steve C R Williams Journal: Cereb Cortex Date: 2003-02 Impact factor: 5.357
Authors: Rowena Handley; Fernando O Zelaya; A A T Simone Reinders; Tiago Reis Marques; Mitul A Mehta; Ruth O'Gorman; David C Alsop; Heather Taylor; Atholl Johnston; Steve Williams; Philip McGuire; Carmine M Pariante; Shitij Kapur; Paola Dazzan Journal: Hum Brain Mapp Date: 2012-03-25 Impact factor: 5.038
Authors: T A Pollak; S De Simoni; B Barimani; F O Zelaya; J M Stone; M A Mehta Journal: Psychopharmacology (Berl) Date: 2015-10-05 Impact factor: 4.530
Authors: Henri J M M Mutsaerts; Rebecca M E Steketee; Dennis F R Heijtel; Joost P A Kuijer; Matthijs J P van Osch; Charles B L M Majoie; Marion Smits; Aart J Nederveen Journal: MAGMA Date: 2015-01-15 Impact factor: 2.310
Authors: Jatinder S Minhas; William Rook; Ronney B Panerai; Ryan L Hoiland; Phil N Ainslie; Jonathan P Thompson; Amit K Mistri; Thompson G Robinson Journal: Br J Anaesth Date: 2019-12-06 Impact factor: 9.166
Authors: Antita Adriaens; Kathelijne Peremans; Tim Waelbers; Eva Vandermeulen; Siska Croubels; Luc Duchateau; André Dobbeleir; Kurt Audenaert; Jos Eersels; Simon Vermeire; Bart De Spiegeleer; Ingeborgh Polis Journal: PLoS One Date: 2014-10-08 Impact factor: 3.240
Authors: Robert Gear; Lino Becerra; Jaymin Upadhyay; James Bishop; Diana Wallin; Gautam Pendse; Jon Levine; David Borsook Journal: PLoS One Date: 2013-01-08 Impact factor: 3.240
Authors: Duncan J Hodkinson; Kristina Krause; Nadine Khawaja; Tara F Renton; John P Huggins; William Vennart; Michael A Thacker; Mitul A Mehta; Fernando O Zelaya; Steven C R Williams; Matthew A Howard Journal: Neuroimage Clin Date: 2013 Impact factor: 4.881
Authors: Niklaus Denier; Hana Gerber; Marc Vogel; Markus Klarhöfer; Anita Riecher-Rossler; Gerhard A Wiesbeck; Undine E Lang; Stefan Borgwardt; Marc Walter Journal: PLoS One Date: 2013-09-10 Impact factor: 3.240